Sichuan Kelun Pharmaceutical Co., Ltd. (SHE:002422)
China · Delayed Price · Currency is CNY 39.97
-0.38 (-0.94%)
Sep 8, 2025, 1:45 PM CST
SHE:002422 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2016 - 2020 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 | 2016 - 2020 |
Net Income | 2,136 | 2,936 | 2,456 | 1,705 | 1,103 | 829.39 | Upgrade |
Depreciation & Amortization | 1,345 | 1,281 | 1,244 | 1,185 | 1,218 | 1,155 | Upgrade |
Other Amortization | 32.11 | 17.28 | 21.74 | 13.11 | 7.55 | 5.93 | Upgrade |
Loss (Gain) From Sale of Assets | -6.63 | -0.81 | -2.63 | -5.4 | 7.94 | 21.45 | Upgrade |
Asset Writedown & Restructuring Costs | 65.85 | 65.85 | 58.62 | 1.93 | 5.26 | 0.34 | Upgrade |
Loss (Gain) From Sale of Investments | -286.81 | -364.88 | -373.58 | -244.68 | -220.34 | -94.82 | Upgrade |
Provision & Write-off of Bad Debts | 72.95 | 73.41 | 36.21 | 47.75 | 36.82 | 52.47 | Upgrade |
Other Operating Activities | 335.91 | 672.17 | 647.31 | 535.93 | 357.07 | 793.64 | Upgrade |
Change in Accounts Receivable | 69.76 | -27.76 | 1,088 | -905.52 | 625.71 | 67.73 | Upgrade |
Change in Inventory | -480.84 | -84.66 | -645.26 | 168.36 | 107.42 | -129.56 | Upgrade |
Change in Accounts Payable | -261.2 | -173.99 | 313.96 | 579.36 | -365.49 | -405.45 | Upgrade |
Change in Other Net Operating Assets | 160.78 | 178.55 | 218.55 | 71.31 | - | - | Upgrade |
Operating Cash Flow | 3,150 | 4,493 | 5,337 | 3,127 | 2,847 | 2,219 | Upgrade |
Operating Cash Flow Growth | -29.28% | -15.82% | 70.68% | 9.83% | 28.28% | 0.12% | Upgrade |
Capital Expenditures | -1,537 | -1,678 | -1,769 | -896.7 | -990.56 | -1,231 | Upgrade |
Sale of Property, Plant & Equipment | 15.6 | 8.36 | 1.28 | 12.72 | 7.98 | 6.08 | Upgrade |
Cash Acquisitions | -13.26 | -2.51 | - | - | - | - | Upgrade |
Divestitures | -66.06 | -40.52 | 80.79 | 5.93 | -30.14 | 623.5 | Upgrade |
Investment in Securities | -822.55 | -316.01 | -1,808 | -89.08 | -578.99 | -381.64 | Upgrade |
Other Investing Activities | 236.07 | 209.57 | 124.55 | 110.03 | 61.92 | 77.66 | Upgrade |
Investing Cash Flow | -2,188 | -1,819 | -3,370 | -857.1 | -1,530 | -905.28 | Upgrade |
Long-Term Debt Issued | - | 4,914 | 4,028 | 10,358 | 9,004 | 11,614 | Upgrade |
Long-Term Debt Repaid | - | -6,720 | -7,319 | -10,641 | -9,445 | -10,988 | Upgrade |
Net Debt Issued (Repaid) | -1,501 | -1,806 | -3,291 | -283.2 | -441.32 | 625.8 | Upgrade |
Issuance of Common Stock | 3.14 | 3.14 | 15.28 | - | 30 | - | Upgrade |
Repurchase of Common Stock | - | - | - | -151.7 | -226.15 | -135.11 | Upgrade |
Common Dividends Paid | -1,318 | -1,812 | -1,127 | -1,033 | -995.9 | -1,132 | Upgrade |
Other Financing Activities | 1,563 | 309.82 | 2,343 | 1,061 | 362.61 | -80.79 | Upgrade |
Financing Cash Flow | -1,253 | -3,304 | -2,059 | -407.26 | -1,271 | -722.11 | Upgrade |
Foreign Exchange Rate Adjustments | -13.44 | -12.78 | 5.19 | 7.93 | -8.27 | -28.21 | Upgrade |
Net Cash Flow | -304.44 | -643.56 | -86.83 | 1,871 | 38.31 | 563.79 | Upgrade |
Free Cash Flow | 1,612 | 2,815 | 3,568 | 2,230 | 1,857 | 988.5 | Upgrade |
Free Cash Flow Growth | -34.30% | -21.11% | 59.98% | 20.13% | 87.82% | 11.61% | Upgrade |
Free Cash Flow Margin | 8.46% | 12.90% | 16.63% | 11.71% | 10.75% | 6.00% | Upgrade |
Free Cash Flow Per Share | 1.01 | 1.78 | 2.31 | 1.50 | 1.31 | 0.69 | Upgrade |
Cash Income Tax Paid | 2,236 | 2,769 | 2,576 | 2,081 | 1,876 | 1,537 | Upgrade |
Levered Free Cash Flow | 981.92 | 2,155 | 1,700 | 1,235 | 1,803 | 237.91 | Upgrade |
Unlevered Free Cash Flow | 1,054 | 2,249 | 1,926 | 1,532 | 2,127 | 584.7 | Upgrade |
Change in Working Capital | -544.78 | -187.19 | 1,249 | -111.89 | 332.01 | -542.77 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.